NCT00171210 · Interventional trial
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
Overall registry status Completed
Phase 3
Conditions Transfusional Iron Overload in β-thalassemia
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory